This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,958.16 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through November 8, 2024.
The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
The contract award was not designated with any set-aside requirements, indicating open competition.
Generated 2/6/25, 9:11 AM